NORCET 3 - 2022 (Shift-1)
Pharmacology
Easy

A patient is on heparin therapy, which of the following test is prescribe to assess the effectiveness of heparin therapy?

Appeared in: NORCET 3 - 2022 (Shift-1)

Explanation

  • The Activated Partial Thromboplastin Time (aPTT) is the standard laboratory test used to monitor the therapeutic effectiveness of unfractionated heparin.
  • Heparin primarily affects the intrinsic and common pathways of the coagulation cascade, and the aPTT test measures the speed of clotting through these pathways.
  • The therapeutic goal for heparin therapy is an aPTT level that is 1.5 to 2.5 times the normal control value, which is typically between 45 and 70 seconds.
  • Monitoring is crucial to ensure the dose is high enough to prevent thrombosis but not so high as to cause spontaneous bleeding.

Why Other Options Were Wrong

  • Option A: Prothrombin Time (PT) measures the integrity of the extrinsic and common coagulation pathways.
  • Option C: The International Normalized Ratio (INR) is a standardized way of reporting the PT result, making it consistent across different laboratories.
  • Option D: This option is incorrect because only aPTT is the appropriate test for monitoring standard heparin therapy among the choices given.

Related Visual

Visual explanation — Related Visual
  • Visual 1: Flowchart - A diagram of the coagulation cascade, highlighting the intrinsic pathway (measured by aPTT and affected by heparin) and the extrinsic pathway (measured by PT/INR and affected by warfarin).
  • Visual 2: Table - A comparison table showing different anticoagulants (Unfractionated Heparin, LMWH, Warfarin), their mechanism of action, the laboratory test used for monitoring, and the target therapeutic range.
Clinical Relevance
  • Nursing practice connection: Use the key finding related to Laboratory monitoring of anticoagulant therapy to guide bedside assessment, documentation, and the next nursing action.
  • Nurses are responsible for obtaining blood samples for aPTT at the correct intervals (e.g., 4-6 hours after initiation or a dose change) and adjusting heparin infusion rates based on institutional protocols.
  • A critical nursing role is monitoring for signs of bleeding (e.g., hematuria, melena, bruising, epistaxis) and for signs of heparin-induced thrombocytopenia (HIT), a serious complication.
  • Patient safety is paramount. A subtherapeutic aPTT increases the risk of clotting, while a supratherapeutic aPTT increases the risk of life-threatening hemorrhage.
How to Approach the Question
  • First, identify the core of the question: it's asking for the specific lab test to monitor heparin.
  • This is a factual recall question common in pharmacology. Access your knowledge about the two main anticoagulant pathways.
  • Recall that heparin affects the intrinsic pathway. The mnemonic 'HePTT' can help you remember: Heparin is monitored by PTT (or aPTT).
  • Recall that warfarin (Coumadin) affects the extrinsic pathway. The mnemonic 'War-PT' can help: Warfarin is monitored by PT (and its standardized version, INR).
  • Evaluate the options based on this knowledge. 'Prothrombin time' and 'INR' are for warfarin. 'Activated Partial thromboplastin time (aPTT)' is for heparin.
  • Therefore, select aPTT as the correct answer and eliminate the other options.
Concept Tested & Keywords
  • Concept Tested: Laboratory monitoring of anticoagulant therapy
  • Stem keywords: heparin therapy, test, assess effectiveness
  • Lead-in keywords: which of the following
  • Negative lead-in flag: false

Question ID

QaiSqWyCaO8lrbpf7A-Ya3

Practise the full NORCET 3 - 2022 (Shift-1)

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Drug Affecting Blood & Blood Formation Questions

More NORCET 3 - 2022 (Shift-1) Questions

A patient is on heparin therapy, which of the following test is prescribe to assess the effectiveness of hepa… - NORCET 3 - 2022 (Shift-1) | NPrep